Methods for treating atopic dermatitis by administering an il-4r antagonist

Disclosed is a pharmaceutical composition comprising an anti-interleukin-4 receptor antibody for use in the treatment of moderate-to-severe atopic dermatitis in a patient, wherein the patient is resistant, non-responsive or inadequately responsive to topical corticosteroids or topical calcineurin in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Radin, Allen, Rocklin, Ross, Ardeleanu, Marius, Weinstein, Steven, Kirkesseli, Stephane, Ming, Jeffrey, Hamilton, Jennifer, Graham, Neil, Kundu, Sudeep
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed is a pharmaceutical composition comprising an anti-interleukin-4 receptor antibody for use in the treatment of moderate-to-severe atopic dermatitis in a patient, wherein the patient is resistant, non-responsive or inadequately responsive to topical corticosteroids or topical calcineurin inhibitors